TY  - JOUR
AU  - Quintanal-Villalonga, Álvaro
AU  - Carranza-Carranza, Andrés
AU  - Meléndez, Ricardo
AU  - Ferrer, Irene
AU  - Molina-Pinelo, Sonia
AU  - Paz-Ares, Luis
PY  - 2017
DO  - 10.1016/j.cllc.2017.05.008
UR  - http://hdl.handle.net/10668/11272
T2  - Clinical lung cancer
AB  - The identification of prognostic biomarkers for lung squamous-cell carcinoma (SCC) pathology is crucial because of its poor prognosis. A variant of the FGFR4 (fibroblast growth factor receptor 4) gene, FGFR4-388Arg, has been associated with prognosis...
LA  - en
KW  - Biomarker
KW  - Lung squamous cell carcinoma
KW  - MAPK
KW  - Prognosis
KW  - rs351855
KW  - Aged
KW  - Aged, 80 and over
KW  - Biomarkers, Tumor
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Carcinoma, Squamous Cell
KW  - Chemotherapy, Adjuvant
KW  - Disease-Free Survival
KW  - Female
KW  - Genotype
KW  - Humans
KW  - Immunohistochemistry
KW  - Lung Neoplasms
KW  - Lymphatic Metastasis
KW  - MAP Kinase Signaling System
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Prognosis
KW  - Proto-Oncogene Proteins c-akt
KW  - Receptor, Fibroblast Growth Factor, Type 4
KW  - Survival Rate
TI  - Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement.
TY  - research article
VL  - 18
ER  -